Algorithms for Treating Dyslipidemia in Youth
- 31 July 2023
- journal article
- review article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 25 (8) , 495-507
Abstract
Purpose of Review The goal of this article is to review algorithms for treating dyslipidemia in youth, discuss pitfalls, propose enhanced algorithms to address pitfalls, and consider future directions. Recent Findings The presence of modifiable and non-modifiable cardiovascular disease (CVD) risk factors during childhood is associated with CVD-related events in adulthood. Recent data has shown that childhood initiation of statin therapy in youth < 18 years of age with familial hypercholesterolemia reduces the risk of adult CVD. However, pediatric dyslipidemia remains undertreated in part due to a lack of primary health care providers with adequate understanding of screening guidelines and pediatric lipidologists with experience in treatment and follow-up of this unique population. Management algorithms have been published by the National Heart, Lung, and Blood Institute and American Heart Association as tools to empower clinicians to manage dyslipidemia. We propose enhanced algorithms, which incorporate recently approved pharmacotherapy to address the management gaps. Future algorithms based upon clinical risk scores may enhance treatment and improve outcomes. Summary Algorithms for dyslipidemia management which target youth < 18 years of age are tools which empower clinicians to manage dyslipidemia in this unique population. Enhanced algorithms may help address pitfalls. We acknowledge the need for further risk assessment tools in pediatrics for tailored dyslipidemia management.Keywords
This publication has 54 references indexed in Scilit:
- Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology, 2011
- Lipid Screening and Cardiovascular Health in ChildhoodPediatrics, 2008
- Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysisBMJ, 2007
- Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task ForcePediatrics, 2007
- Cardiovascular Risk Reduction in High-Risk Pediatric PatientsCirculation, 2006
- Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The search for diabetes in youth studyThe Journal of Pediatrics, 2006
- American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in ChildhoodCirculation, 2003
- Distributions and Trends of Serum Lipid Levels among United States Children and Adolescents Ages 4–19 Years: Data from the Third National Health and Nutrition Examination SurveyPreventive Medicine, 1998
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998
- Lipid and lipoprotein distributions in white children ages 6–19 yr. The lipid research clinics program prevalence studyJournal of Chronic Diseases, 1981